Genocea Biosciences, Inc.
GNCADelisted Jun 2, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001457612
Genocea Biosciences, Inc. was delisted on Jun 2, 2022; its insiders filed their last Form 4 on Jun 3, 2022; 40 institutions reported holding it in 13F filings for Q1 2022, worth $42.1M in total; no superinvestor held it.
13F holders, Q4 2021
Institutional positions in Genocea Biosciences, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- +2 vs. Q3 2021
- Shares held
- 33.5M
- −284.2K (−0.8%) vs. Q3 2021
- Total value
- $38.9M
- −$26.0M (−40.1%) vs. Q3 2021
- New holders
- 6
- 7 more added
- Sold out
- 4
- 6 more reduced
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GNCA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 1 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 1 | $0 |
| Q4 2024 | 1 | $0 |
| Q3 2024 | 1 | $1 |
| Q2 2024 | 1 | $0 |
| Q1 2024 | 1 | $0 |
| Q4 2023 | 1 | $1 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 1 | $4.00K |
| Q2 2022 | 5 | $92.0K |
| Q1 2022 | 40 | $42.1M |
| Q4 2021 | 41 | $38.9M |
| Q3 2021 | 40 | $65.3M |
| Q2 2021 | 46 | $79.4M |
| Q1 2021 | 42 | $86.3M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Genocea Biosciences, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| NEA Management Company, LLC | 10,376,936 | $12.0M | 0.24% | 00.0% | Unchanged |
| Avoro Capital Advisors LLC | 5,084,184 | $5.90M | 0.10% | 00.0% | Unchanged |
| BVF Inc | 4,012,404 | $4.65M | 0.17% | 00.0% | Unchanged |
| Commodore Capital LP | 3,079,756 | $3.57M | 0.83% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 2,652,974 | $3.08M | 0.01% | 00.0% | Unchanged |
| Kingdon Capital Management, L.L.C. | 1,972,056 | $2.29M | 0.34% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,795,495 | $2.08M | 0.00% | −58,331−3.1% | Reduced |
| Vanguard Group Inc | 1,574,879 | $1.83M | 0.00% | +11,778+0.8% | Added |
| Boxer Capital, LLC | 1,134,453 | $1.32M | 0.05% | 00.0% | Unchanged |
| ABG Innovation Capital Partners III GP Ltd | 375,000 | $435.0K | 25.16% | 00.0% | Unchanged |
| HighTower Advisors, LLC | 212,260 | $246.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 206,880 | $239.0K | 0.00% | +20,938+11.3% | Added |
| Millennium Management LLC | 196,433 | $228.0K | 0.00% | −180,912−47.9% | Reduced |
| Ikarian Capital, LLC | 196,821 | $228.0K | 0.07% | 00.0% | Unchanged |
| BlackRock Inc. | 185,443 | $215.0K | 0.00% | +4,452+2.5% | Added |
| Northern Trust Corp | 70,837 | $82.0K | 0.00% | +14,368+25.4% | Added |
| Bank of America Corp | 57,390 | $67.0K | 0.00% | +270.0% | Added |
| Group One Trading, L.P. | 44,014 | $51.0K | 0.00% | −17,600−28.6% | Reduced |
| Commonwealth Equity Services, LLC | 31,981 | $37.0K | 0.00% | +10,576+49.4% | Added |
| Simplex Trading, LLC | 31,015 | $35.0K | 0.00% | +31,015 | New |
| Renaissance Technologies LLC | 27,500 | $32.0K | 0.00% | +27,500 | New |
| Two Sigma Advisers, LP | 22,677 | $26.0K | 0.00% | −119,800−84.1% | Reduced |
| Acadian Asset Management LLC | 21,741 | $25.0K | 0.00% | +21,741 | New |
| State Street Corp | 19,684 | $23.0K | 0.00% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 19,916 | $23.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 16,305 | $19.0K | 0.00% | 00.0% | Unchanged |
| Personal Capital Advisors Corp | 15,000 | $17.0K | 0.00% | 00.0% | Unchanged |
| WealthTrust Axiom LLC | 15,000 | $17.0K | 0.01% | 00.0% | Unchanged |
| Morgan Stanley | 13,636 | $15.0K | 0.00% | −2,033−13.0% | Reduced |
| Virtu Financial LLC | 12,503 | $15.0K | 0.00% | +12,503 | New |
| Capital Asset Advisory Services LLC | 11,766 | $14.0K | 0.00% | 00.0% | Unchanged |
| Empirical Asset Management, LLC | 10,000 | $12.0K | 0.01% | +10,000 | New |
| Wells Fargo & Company | 9,462 | $11.0K | 0.00% | −206−2.1% | Reduced |
| Vectors Research Management, LLC | 6,000 | $7.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 6,058 | $7.00K | 0.00% | +156+2.6% | Added |
| ACT Capital Management, LLC | 5,000 | $6.00K | 0.00% | 00.0% | Unchanged |
| First Manhattan Co | 2,500 | $2.00K | 0.00% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 1,037 | $1.00K | 0.00% | 00.0% | Unchanged |
| Artemis Wealth Advisors, LLC | 1,137 | $1.00K | 0.00% | 00.0% | Unchanged |
| Cutler Group LP | 900 | $1.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,129 | $1.00K | 0.00% | +1,129 | New |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −57,836−100.0% | Sold out |
| First Republic Investment Management, Inc. | 0 | $0 | 0.00% | −12,285−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −800−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −625−100.0% | Sold out |
| Polaris Venture Management Co. V, L.L.C. | – | – | – | – | Not filed |